ADIPOQ and type 2 diabetes mellitus: A study performed in humans showed that circulating ZAG levels were lower in type 2 diabetes patients than in controls, and circulating ZAG levels were correlated positively with HDL-C and adiponectin, and correlated negatively with body mass index (BMI), TG, and HOMA-IR (31).